Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing
- PMID: 2100526
Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing
Abstract
To evaluate the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing, three groups of women were studied by computerized bone densitometry at the radius mid-point and at the distal point, modified according to the Abwrey technique. All women were in apparent good health and never had estrogen therapy. In the first group there were 64 women aged between 30 and 50 who were ovariectomized between 25 and 35 years of age. The second group was made up of 309 women between 50 and 55 years. In the third group there were 136 women aged 30-50 with normal ovaric function. The ordinary functions of linear polynomial regression were used to describe the variations in density with age. The percentage of postmenopausal bone loss was determined by calculating the BMC value at the start of the menopause and again twenty years later, according to the linear regression equation of postmenopausal period of each group of women in the study. The women who had natural menopause showed an average bone loss per year of 1.63% at the mid radius and 1.0% at the distal point. The ovariectomized women had an average loss of 0.85% at the mid point and 0.66% at the distal point. No significant decrease of bone mass was found before menopause. From a comparison between the two groups of women with analogous periods of menopause, it comes out that, during the first 20 years of natural menopause, estrogen deficiency is responsible for 52.5%-66.4% of the bone mineral loss, the remaining amount being attributable to other causes, connected with ageing. Estrogen deficiency is therefore, the principal factor causing bone mineral loss in natural menopause.
Similar articles
-
Pattern of bone loss in surgical menopause: a preliminary report.J Med Assoc Thai. 1997 Nov;80(11):731-7. J Med Assoc Thai. 1997. PMID: 9385771
-
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.N Engl J Med. 1984 Nov 15;311(20):1273-5. doi: 10.1056/NEJM198411153112002. N Engl J Med. 1984. PMID: 6493283
-
[Relative contribution of ageing and menopause to the changes of lumbar bone density in 1,400 Beijing women].Zhonghua Fu Chan Ke Za Zhi. 1997 Sep;32(9):532-4. Zhonghua Fu Chan Ke Za Zhi. 1997. PMID: 9639752 Chinese.
-
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.J Bone Miner Res. 1998 May;13(5):763-73. doi: 10.1359/jbmr.1998.13.5.763. J Bone Miner Res. 1998. PMID: 9610739 Review.
-
Effects of estrogen/androgen therapy on bone mineral density parameters.J Reprod Med. 2001 Mar;46(3 Suppl):325-31. J Reprod Med. 2001. PMID: 11304880 Review.
Cited by
-
Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.Ann Lab Med. 2012 Jan;32(1):23-30. doi: 10.3343/alm.2012.32.1.23. Epub 2011 Dec 20. Ann Lab Med. 2012. PMID: 22259775 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical